A study on the long-term safety of CAR T-cell therapy for B-cell lymphoma patients reveals a favourable safety profile with ...

During a Case-Based Roundtable® event, Natalie Galanina, MD, reviewed how outcomes have changed in patients with primary ...

Among many things, it's the real passion and raw reactions that have more than 90,000 people following metro Detroit native ...

The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for autoimmune diseases, with chimeric antigen receptor (CAR)-T therapies ...

Using a database that tracks the health outcomes of twins, scientists have found more evidence that tattoo ink may be linked ...

Patients who receive certain cancer treatments are at greater risk of secondary malignancies and must be educated accordingly ...

Q4 2024 Earnings Conference Call March 4, 2025 8:00 AM ETCompany ParticipantsCourtney Dugan - Head-IRMichael Rossi ...

Subtle signs of skin cancer you shouldn't ignore When the weather gets warmer and daylight hours longer, people are more ...

Also, it is unclear whether the onset of pseudoprogression is influenced by co-factors such as prior radiation therapy or the presence of brain metastases. Given that immune therapy with ...

Fred Locke, MD, Moffitt Cancer Center, explains why this hematologic cancer is such an attractive target for chimeric antigen ...

Peripheral T-cell lymphomas are a rare and heterogeneous type of lymphoma, with geographical and ethnic variations in histological subtypes that differ across the world.1 In The Lancet Haematology, ...